SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

LISTING ON EURONEXT AMSTERDAM

20 Aug 2007 07:00

Accsys Technologies PLC20 August 2007 20th August 2007 AIM: AXS ACCSYS TO LIST ON EURONEXT AMSTERDAM Accsys Technologies PLC (''Accsys'' or the "Company") announces its intention,with reference to its earlier release dated 28 June 2007, to seek a listing onEuronext Amsterdam by NYSE Euronext and conduct a share offering. The intendedoffering is expected to consist of new ordinary shares offered by the Companyand existing ordinary shares offered by certain Accsys shareholders. It isexpected that the listing will be completed before the end of the year. Fortis has been appointed Sole Lead Manager and Bookrunner for the intendedtransaction. For further information, please contact: Accsys Technologies PLC William Paterson-Brown, +44 (0) 20 8144 2510 Chairman & Chief Executive Parkgreen Communications Justine Howarth +44 (0) 20 7851 7480Citigate First Financial B.V Frank Jansen +31 (0) 20 5754 024 Information on the Accsys Group of Companies: Accsys Technologies PLC (www.accsysplc.com) - is an environmental science andtechnology company whose primary focus is on the production and licensing ofAccoyaTM via its 100% owned subsidiary, Titan Wood (www.titanwood.com), withmanufacturing operations based in Arnhem, The Netherlands. AccoyaTM,manufactured through the Company's proprietary acetylation process, exhibitssuperior dimensional stability and durability compared with other natural andtreated timber. Accsys is also developing technology to modify wood fibre toenable future production of a range of panel products. Accsys' operations comprise three principal business units: (i) the AccoyaTMproduction facility located in Arnhem, The Netherlands; (ii) technologydevelopment focused on a programme of continuous improvements to the processengineering and operating protocols for the acetylation of wood as well as thedevelopment of technology for the acetylation of wood fibre; and (iii) thelicensing of technology for the production of AccoyaTM across the globe. Accsys Technologies PLC shares are traded on the London Stock Exchange AIMmarket under the symbol 'AXS'. AccoyaTM wood (www.accoya.info) is produced using a patented process thateffectively converts sustainably grown softwoods and non-durable hardwoods intowhat is best described as a 'new wood species'. Distinguished by its durability,dimensional stability and, perhaps most importantly, its reliability (in termsof consistency of both supply and quality), AccoyaTM wood is particularly suitedto exterior applications where performance and appearance are valued. Unlikemost tropical and European hardwoods, its colour does not degrade when exposedto ultraviolet light. Moreover, the AccoyaTM wood production process does notcompromise the wood's strength or machinability. The combination of UVresistance, dimensional stability, durability and retained strength means thatAccoyaTM wood offers a wealth of new opportunities to architects, designers andspecifiers. For marine uses where weight is also important, AccoyaTM wood forthe first time provides boat builders with a wood that is strong and durable,which retains its natural beauty for far longer, without a dramatic weightincrease. ACCOYA is a registered trademark owned by Titan Wood Limited Other information: Not for release, distribution or publication into or in the United States,Australia, Canada, or Japan. This announcement is not an offer to sell or a solicitation of any offer to buythe Company's securities (the "Securities") in the United States or in any otherjurisdiction. The Securities have not been and will not be registered under the US SecuritiesAct of 1933, as amended (the "Securities Act") and may not be offered or sold inthe United States unless registered under the Securities Act or an exemptionfrom such registration is available. No public offering of Securities of theCompany is being made in the United States. The offer to acquire securities pursuant to the proposed offering will be made,and any investor should make his investment, solely on the basis of informationthat will be contained in the prospectus to be made generally available in TheNetherlands in connection with such offering. When made generally available,copies of the prospectus may be obtained at no cost from Accsys or Fortis orthrough the website of Euronext Amsterdam (Dutch residents only). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSTotal Voting Rights
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.